Market Overview

Medtronic Narrows FY13 EPS Outlook

Related MDT
Medtronic Completes Acquisition of Twelve, Inc.
Medtronic Initiates Global Study of Minimally Invasive Technology to Aid Lung Cancer Diagnosis

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance


Related Articles (MDT)

Get Benzinga's Newsletters